KCNK5, a two-pore domain potassium channel, is in the top 1% of underexpressed genes in melanoma and top 5% of underexpressed genes in breast, colorectal, renal, and liver cancers, and there is increasing interest in the role of potassium channels in cancer (Williams et al., 2013). This evidence concerns the gene KCNA3 and melanoma.